Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Hidalgo

Showing results (21-30 of 384) with videos related to

Pageof 39
Sort By:
Molecular Cancer Therapeutics|May 2, 2006
Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancerAntonio Jimeno, Manuel Hidalgo
Critical Reviews in Oncology/Hematology|July 18, 2006
Multitargeted therapy: can promiscuity be praised in an era of political correctness?Antonio Jimeno, Manuel Hidalgo
Plos One|June 28, 2014
Forensic analysis of Venezuelan elections during the Chávez presidencyRaúl Jiménez, Manuel Hidalgo
Advances in Experimental Medicine and Biology|August 12, 2003
Development of the epidermal growth factor receptor inhibitor Tarceva (OSI-774)Viktor Grünwald, Manuel Hidalgo
Clinical Lung Cancer|December 5, 2003
Promising developments in targeted therapies for non-small-cell lung cancerDesirée Hao, Manuel Hidalgo
Seminars in Oncology|June 13, 2003
Development of the epidermal growth factor receptor inhibitor OSI-774Viktor Grünwald, Manuel Hidalgo
Expert Review of Anticancer Therapy|August 23, 2005
Promises and pitfalls in the prediction of antiepidermal growth factor receptor activityAntonio Jimeno, Manuel Hidalgo
Current Opinion in Investigational Drugs (London, England : 2000)|June 21, 2006
Targeting mTOR for cancer treatmentBelen Rubio-Viqueira, Manuel Hidalgo
World Journal of Gastroenterology|November 9, 2007
Exploiting novel molecular targets in gastrointestinal cancersWen W Ma, Manuel Hidalgo
Advances in Experimental Medicine and Biology|December 14, 2006
Targeting mTOR for cancer treatmentBelen Rubio-Viqueira, Manuel Hidalgo
Pageof 39

Showing results (21-30 of 384) with videos related to

Sort By:
Pageof 39
Molecular Cancer Therapeutics|May 2, 2006
Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancerAntonio Jimeno, Manuel Hidalgo
Critical Reviews in Oncology/Hematology|July 18, 2006
Multitargeted therapy: can promiscuity be praised in an era of political correctness?Antonio Jimeno, Manuel Hidalgo
Plos One|June 28, 2014
Forensic analysis of Venezuelan elections during the Chávez presidencyRaúl Jiménez, Manuel Hidalgo
Advances in Experimental Medicine and Biology|August 12, 2003
Development of the epidermal growth factor receptor inhibitor Tarceva (OSI-774)Viktor Grünwald, Manuel Hidalgo
Clinical Lung Cancer|December 5, 2003
Promising developments in targeted therapies for non-small-cell lung cancerDesirée Hao, Manuel Hidalgo
Seminars in Oncology|June 13, 2003
Development of the epidermal growth factor receptor inhibitor OSI-774Viktor Grünwald, Manuel Hidalgo
Expert Review of Anticancer Therapy|August 23, 2005
Promises and pitfalls in the prediction of antiepidermal growth factor receptor activityAntonio Jimeno, Manuel Hidalgo
Current Opinion in Investigational Drugs (London, England : 2000)|June 21, 2006
Targeting mTOR for cancer treatmentBelen Rubio-Viqueira, Manuel Hidalgo
World Journal of Gastroenterology|November 9, 2007
Exploiting novel molecular targets in gastrointestinal cancersWen W Ma, Manuel Hidalgo
Advances in Experimental Medicine and Biology|December 14, 2006
Targeting mTOR for cancer treatmentBelen Rubio-Viqueira, Manuel Hidalgo
Pageof 39